Clinical trial
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Acute Pancreatitis
NCT07267169 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Acute Pancreatitis
- Lead sponsor
- Efferon JSC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- March 30, 2026
- Completion date
- March 31, 2028
- Enrollment
- 150 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
pancreatitis, acute